These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 13699332)

  • 1. [The influence of anabolic substances on myocardial metabolism, their use in the treatment of myocardial disorders].
    FIEGEL G
    Arztl Forsch; 1961 Jul; 15():I/310-7. PubMed ID: 13699332
    [No Abstract]   [Full Text] [Related]  

  • 2. Signalling pathways in ischaemic postconditioning.
    Hausenloy DJ
    Thromb Haemost; 2009 Apr; 101(4):626-34. PubMed ID: 19350104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic therapy for patients with diabetes mellitus and coronary artery disease.
    Rosano GM; Vitale C; Fragasso G
    Am J Cardiol; 2006 Sep; 98(5A):14J-18J. PubMed ID: 16931201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recent findings in the treatment of coronary insufficiency].
    Sodi Pallares D
    Rev Invest (Guadalajara); 1965 Apr; 5(1):169-85. PubMed ID: 5318711
    [No Abstract]   [Full Text] [Related]  

  • 5. [The heart in diabetics].
    Bĕlobrádková J; Filipenský B
    Vnitr Lek; 2003 Dec; 49(12):921-6. PubMed ID: 15040156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anabolic activity of a series of new derivatives of testosterone].
    SALA G; BALDRATTI G; RONCHI R; CLINI V; BERTAZZOLI C
    Sperimentale; 1956; 106(6):490-510. PubMed ID: 13433064
    [No Abstract]   [Full Text] [Related]  

  • 7. Myocardial metabolism: pharmacological manipulation in myocardial ischaemia.
    Mitra B; Panja M
    J Assoc Physicians India; 2005 Jun; 53():552-60. PubMed ID: 16121812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro metabolism of a new derivative of testosterone with a marked anabolic action: 4-chlorotestosterone].
    SALA G; CASTEGNARO E
    Folia Endocrinol Mens Incretologia Incretoterapia; 1958 Jun; 11(3):348-53. PubMed ID: 13574260
    [No Abstract]   [Full Text] [Related]  

  • 9. Is there an ischemic threshold beyond which percutaneous coronary intervention is beneficial in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial?
    Bangalore S; Messerli FH
    Am J Cardiol; 2007 Nov; 100(9):1495. PubMed ID: 17950818
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of coronary atherosclerosis with testosterone associated with vitamin B12].
    FOMINA LG
    Ter Arkh; 1960 Oct; 32():58-61. PubMed ID: 13700555
    [No Abstract]   [Full Text] [Related]  

  • 11. Does glutamate influence myocardial and peripheral tissue metabolism after aortic valve replacement for aortic stenosis?
    Vánky FB; Håkanson E; Jorfeldt L; Svedjeholm R
    Clin Nutr; 2006 Dec; 25(6):913-22. PubMed ID: 16737761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial blood supply by left ventricle-to-coronary artery channel: an old idea revisited.
    Engbers HM; de Zeeuw S; Visser T; Cramer MJ; Gründeman PF
    Int J Cardiol; 2006 Jan; 106(2):145-51. PubMed ID: 16321684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial and coronary sinus purines as indicators of pig heart energy metabolism during reperfusion after extracorporeal circulation.
    Safranow K; Rzeuski R; Listewnik MJ; Jakubowska K; Rać ME; Olszewska M; Chlubek D
    Acta Physiol Scand; 2005 Sep; 185(1):13-23. PubMed ID: 16128693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The influence of halogenated anesthetic agents on the hemodynamics and myocardial metabolism in ischemic heart disease].
    Vasil'ev AV; Nesterova IuV; Brand IaB
    Klin Med (Mosk); 2007; 85(11):42-6. PubMed ID: 18219955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of myocardial metabolism with microdialysis during bypass surgery with cold blood- or Calafiore cardioplegia.
    Pöling J; Rees W; Mantovani V; Klaus S; Bahlmann L; Ziaukas V; Hübner N; Warnecke H
    Eur J Cardiothorac Surg; 2006 Oct; 30(4):597-603. PubMed ID: 16901714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The sudden and unexpected death of a female-to-male transsexual patient.
    Inoue H; Nishida N; Ikeda N; Tsuji A; Kudo K; Hanagama M; Nata M
    J Forensic Leg Med; 2007 Aug; 14(6):382-6. PubMed ID: 17320460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of short term (3 weeks) testosterone treatment on serum inflammatory markers in men undergoing coronary artery stenting.
    Guler N; Batyraliev T; Dulger H; Ozkara C; Tuncer M; Aslan S; Okut H; Agirbasli M
    Int J Cardiol; 2006 May; 109(3):339-43. PubMed ID: 16040142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thinness: its treatment by anabolic drugs, with special reference to the compound 4-hydroxy-17alpha-methyl-testosterone].
    GEROSA HN; MARTORELLI J; BALADO B
    Dia Med; 1960 Nov; 32():2581-6. PubMed ID: 13704716
    [No Abstract]   [Full Text] [Related]  

  • 19. Complete myocardial revascularization: between myth and reality.
    Zimarino M; Calafiore AM; De Caterina R
    Eur Heart J; 2005 Sep; 26(18):1824-30. PubMed ID: 15824076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 17beta-hydroxy-5alpha-androst-1-en-3-one (1-testosterone) is a potent androgen with anabolic properties.
    Friedel A; Geyer H; Kamber M; Laudenbach-Leschowsky U; Schänzer W; Thevis M; Vollmer G; Zierau O; Diel P
    Toxicol Lett; 2006 Aug; 165(2):149-55. PubMed ID: 16621347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.